Humana gains after key Medicare Advantage rating rises

By Catherine Dunn Humana stock gained 13% in after hours trading Thursday after the federal government released new ratings data on Medicare Advantage plans, showing that Humana achieved a four-star rating on a key contract closely watched by Wall Street. After a sharp fall two years ago, the insurer was looking to make a comeback on the new 2027 ratings, which were anticipated this week. The ratings are tied to financial bonuses in the Medicare Advantage program, and Humana's results were expected to test the stock that has soared about 50% this year. Humana made big strides Thursday, according to a Leerink Partners analysis of the latest data.

is the clearest positive big winner in our 2027 Stars analysis," Leerink said in a client note. Leerink estimates that about 96% of Humana's members will be in plans rated four stars and higher for 2027, up from 42% this year, based on June enrollment figures. As seniors begin to shop for Medicare health coverage this month, the rating system is meant to help them compare the quality of plans, on a scale of one to five stars. For insurers and Wall Street, star ratings are an incredibly important metric because they determine quality bonus payments to insurers from the government.

Plans rated four stars and above are eligible for the bonuses. This year alone, those bonus payments are expected to total more than $13 billion in aggregate. At Humana, "getting the quality bonus payment back on some of their large contracts is empirical to the margin recovery story," Leerink Partners analyst Whit Mayo told Barron's in an interview this week. " The challenge for Humana started two years ago, when the insurer saw a ratings drop, and went from having more than 90% of its members in a plan rated at least four stars, down to about 25%.

At the time, Humana said it had narrowly missed thresholds on a small number of measures used to calculate stars. That reduction impacted Humana's ability to collect bonuses this year. When the 2026 ratings were announced last year, the results continued to show a gap between Humana and industry peers CVS Health and UnitedHealth Group, each with more than 80% of their members in plans with four or more stars this year, according to Leerink. On Thursday, both CVS Health and UnitedHealth Group saw some decline in that measure for 2027, with about 70% of each company's membership in a four-star or higher plan next year, Leerink found.

50%. Humana didn't immediately respond to a request for comment Thursday. The company was aiming for a boost in 2027 stars, which translate to bonus payments in 2028. Improving the ratings wasn't going to be an overnight fix.

Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics. " The insurer is "very focused on consumer engagement," said Mayo. " A question for Wall Street was just how much the company needed to improve this time around, particularly when it came to one of its largest Medicare Advantage contracts, known as H5216. That contract ultimately moved up to a four-star rating, new data show.

Humana stock gains have surpassed UnitedHealth, which is up about 12% this year, and CVS Health, up nearly 11%. com This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires October 08, 2026 20:13 ET (00:13 GMT) Copyright (c) 2026 Dow Jones & Company, Inc.

The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.